Financhill
Back

Amicus Therapeutics Stock Predictions

Amicus Therapeutics Stock Forecast

  • Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 14.1% based on the past 17 years of stock performance.
  • Amicus Therapeutics has risen higher in 8 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 47.06%
  • Is Amicus Therapeutics Stock Undervalued?
    The current Amicus Therapeutics [FOLD] share price is $11.00. The Score for FOLD is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • FOLD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Amicus Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 14.1% based on the past 17 years of stock performance.

Amicus Therapeutics Stock Rating

Sell
48
Amicus Therapeutics (FOLD) is a Sell

Is Amicus Therapeutics overpriced?

  • Amicus Therapeutics has risen higher in 8 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 47.06%

Amicus Therapeutics Stock Price History

Is FOLD stock going to rise?

  • The current trend is relatively stagnant and FOLD is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
amicusrx.com

52-Week Data

52-Week High:
14.57
52-Week Low:
9.02

Prediction Charts

Market Cap:
3.26B
Price in USD:
11.00
Volume:
2.25M
Beta:
1.02

Technical Analysis

SMA50:
11.00
SMA100:
10.48
SMA200:
11.43
52-Wk Change:
-14.73%

Stock Predictions

  • Is Amicus Therapeutics stock public?
    Yes, Amicus Therapeutics is a publicly traded company.
  • What is the Amicus Therapeutics stock quote today?
    The Amicus Therapeutics stock price is 11.00 USD today.
  • How to buy Amicus Therapeutics stock online?
    You can buy Amicus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-30 11.38 11.61 11.65 11.33
Sep-3 11.58 11.62 11.99 11.52
Sep-4 11.51 11.52 11.60 11.32
Sep-5 11.59 11.69 11.74 11.28
Sep-6 11.91 11.67 11.91 11.45
Sep-9 11.65 11.50 11.70 11.44
Sep-10 11.50 11.25 11.51 11.25
Sep-11 11.17 11.27 11.32 11.15
Sep-12 11.25 11.29 11.36 11.10
Sep-13 11.35 11.30 11.42 11.21
Sep-16 11.34 11.06 11.36 11.02
Sep-17 11.14 11.20 11.37 11.05
Sep-18 11.16 10.91 11.26 10.89
Sep-19 11.13 11.00 11.17 10.98

Amicus Therapeutics Earnings

Amicus Therapeutics Earnings Report: Per Share Amicus Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Amicus Therapeutics Forecast Revenue Growth

Amicus Therapeutics Stock Analysis: Historical quarterly revenues per share for Amicus Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.06 per share, an increase this year of $0.51 per share, and an increase next year of $0.29 per share.

* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.